Literature DB >> 28821910

[German Ophthalmology Internationally].

T Kohnen1,2.   

Abstract

Mesh：

Year:  2017        PMID： 28821910     DOI： 10.1007/s00347-017-0542-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  19 in total

1.  Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction.

Authors:  Bodil Petersen; Maria Deja; Roland Bartholdy; Bernd Donaubauer; Sven Laudi; Roland C E Francis; Willehad Boemke; Udo Kaisers; Thilo Busch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-12-12       Impact factor: 3.619

2.  Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.

Authors:  Ronald Van Beneden; Olivier Gurné; Philippe L Selvais; Sylvie A Ahn; Annie R Robert; Jean-Marie Ketelslegers; Hubert G Pouleur; Michel F Rousseau
Journal:  J Card Fail       Date:  2004-12       Impact factor: 5.712

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Synthesis and pharmacological activity of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acids as selective ET(A) antagonists.

Authors:  Hardik J Patel; Nicole Olgun; István Lengyel; Sandra Reznik; Ralph A Stephani
Journal:  Bioorg Med Chem Lett       Date:  2010-11-15       Impact factor: 2.823

5.  Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?

Authors:  Meejeon Roh; Sarki A Abdulkadir
Journal:  Cancer Biol Ther       Date:  2010-04-26       Impact factor: 4.742

6.  Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis.

Authors:  T Minamino; H Kurihara; M Takahashi; K Shimada; K Maemura; H Oda; T Ishikawa; T Uchiyama; K Tanzawa; Y Yazaki
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

Review 7.  Endothelin-1 in chronic renal failure and hypertension.

Authors:  Richard Larivière; Marcel Lebel
Journal:  Can J Physiol Pharmacol       Date:  2003-06       Impact factor: 2.273

8.  Carotid atherosclerosis in elderly hypertensive patients: potential role of endothelin and plasma antioxidant capacity.

Authors:  A B Skalska; T Grodzicki
Journal:  J Hum Hypertens       Date:  2009-12-17       Impact factor: 3.012

9.  [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].

Authors:  Wen-quan Zhou; Ying-hao Sun; Hong-lin Yin; Zheng-yu Zhang; Jing-ping Ge; Wen Cheng; Hong-qing Ma; Wu Wei; Shui-gen Zhou; Heng-hui Ma; Jian-ping Gao
Journal:  Zhonghua Nan Ke Xue       Date:  2007-08

10.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Authors:  D J Stewart; R D Levy; P Cernacek; D Langleben
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.